An interventional study of day hospital and dietician consultation in Cancer, sponsored by Médipôle Lyon-Villeurbanne. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Médipôle Lyon-Villeurbanne · Not applicable, Interventional, and Supportive care
The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends assessing the nutritional status of each oncology patient early and in a multidisciplinary manner.
This assessment should take into account physical activity and should allow for the patient to be provided with nutritional goals adapted to their new needs. These recommendations aim to combat malnutrition, which sometimes leads to treatment suspension and thus a loss of opportunity for the patient.
9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.
This study's enrollment of 306 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →Médipôle Lyon-Villeurbanne is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Dietician consultation
Other: dietician consultation
mutlidisciplinary care
Other: day hospital
This multidisciplinary day hospital consists of 3 information workshops focused on balanced nutrition, oral nutritional supplements and enrichments as well as artificial feeding. During this day hospital, patients will meet with an endocrinologist nutritionist, a dietitian, and a teacher in adapted physical activity.
dietician consultation
weight loss
Time frame: 1 year
quality of life sf-36
sf-36
Time frame: 1 year
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Médipôle Lyon-Villeurbanne